Biotech Values

[vinmantoo]

(ENTA)—Shionogi antiviral is teratogenic—>out_of_contention_for_best-in-class_COVID_drug:

Their drug is a protease inhibitor as is Paxlovid. The latter shows a decrease in fetal size so his may be a general class effect. The problem is likely off target effects on other proteases, Caspases come to mind. ENTA just released data showing it has very high specificity for the Covid protease (see Dew's message below) so it might not be as problematic for ENTA but time will tell.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168493419)